Indeed, EVs carrying CRISPR/Cas9-encoding plasmids targeting the poly (ADP-ribose) polymerase-1 (PARP-1) gene were shown to block PARP-1 in ovarian cancer cells, demonstrating preserved transcriptional activity of the recombinant DNA cargo during delivery [150]. This evidence concerns the gene PARP1 and ovarian carcinoma.